Recruiting Duchenne Muscular Dystrophy Studies in Boston
About Duchenne Muscular Dystrophy Clinical Trials in Boston
Duchenne muscular dystrophy is a severe genetic disorder characterized by progressive muscle degeneration and weakness, primarily affecting boys. It is caused by mutations in the dystrophin gene. Treatment includes corticosteroids, gene therapies, and supportive care to maintain mobility and function.
There are currently 3 duchenne muscular dystrophy clinical trials recruiting participants in Boston, MA. These studies are seeking a combined 444 participants. Research is being sponsored by ITF Therapeutics LLC, Massachusetts General Hospital, Nationwide Children's Hospital. Clinical trial participation is free and participants receive study-related medical care at no cost.
Duchenne Muscular Dystrophy Clinical Trials in Boston — FAQ
Are there duchenne muscular dystrophy clinical trials in Boston?
Yes, there are 3 duchenne muscular dystrophy clinical trials currently recruiting in Boston, MA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Boston?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Boston research site will contact you about next steps.
Are clinical trials in Boston free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Boston studies also compensate for your time and travel.
What duchenne muscular dystrophy treatments are being tested?
The 3 active trials in Boston are testing new therapies including novel drugs, biologics, and treatment approaches for duchenne muscular dystrophy.
Data updated July 13, 2026 from ClinicalTrials.gov